Centiva Capital LP Acquires New Stake in agilon health, inc. (NYSE:AGL)

Centiva Capital LP purchased a new stake in agilon health, inc. (NYSE:AGLFree Report) during the 3rd quarter, HoldingsChannel reports. The fund purchased 165,665 shares of the company’s stock, valued at approximately $651,000.

Other large investors have also recently modified their holdings of the company. CWM LLC raised its stake in agilon health by 406.5% in the second quarter. CWM LLC now owns 9,081 shares of the company’s stock valued at $59,000 after purchasing an additional 7,288 shares in the last quarter. Simplicity Wealth LLC raised its position in shares of agilon health by 145.1% during the 2nd quarter. Simplicity Wealth LLC now owns 26,210 shares of the company’s stock valued at $171,000 after buying an additional 15,515 shares in the last quarter. J.Safra Asset Management Corp lifted its holdings in shares of agilon health by 626.1% during the 2nd quarter. J.Safra Asset Management Corp now owns 4,204 shares of the company’s stock worth $27,000 after acquiring an additional 3,625 shares during the last quarter. Nisa Investment Advisors LLC purchased a new position in agilon health in the second quarter worth $60,000. Finally, Neo Ivy Capital Management bought a new position in agilon health in the second quarter valued at $1,006,000.

Insiders Place Their Bets

In other news, CEO Steven Sell purchased 20,000 shares of agilon health stock in a transaction that occurred on Thursday, September 12th. The shares were bought at an average cost of $3.36 per share, with a total value of $67,200.00. Following the completion of the purchase, the chief executive officer now directly owns 67,590 shares in the company, valued at approximately $227,102.40. This trade represents a 42.03 % increase in their ownership of the stock. The acquisition was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. 3.20% of the stock is currently owned by company insiders.

Wall Street Analyst Weigh In

AGL has been the subject of several research analyst reports. Evercore ISI dropped their price target on agilon health from $7.00 to $4.00 and set an “in-line” rating for the company in a research note on Tuesday, October 8th. Bank of America lowered agilon health from a “buy” rating to an “underperform” rating and set a $3.00 target price for the company. in a research note on Wednesday, October 2nd. Citigroup decreased their price target on shares of agilon health from $2.50 to $1.75 and set a “sell” rating on the stock in a research note on Wednesday, November 13th. JMP Securities lowered shares of agilon health from an “outperform” rating to a “market perform” rating in a report on Monday, November 11th. Finally, William Blair downgraded shares of agilon health from an “outperform” rating to a “market perform” rating in a research note on Friday, November 8th. Three research analysts have rated the stock with a sell rating, fifteen have given a hold rating and two have issued a buy rating to the company. According to data from MarketBeat, the stock has a consensus rating of “Hold” and a consensus target price of $5.20.

Check Out Our Latest Research Report on AGL

agilon health Price Performance

Shares of agilon health stock opened at $2.17 on Friday. The business has a 50 day moving average of $2.60 and a 200 day moving average of $4.55. agilon health, inc. has a 52 week low of $1.50 and a 52 week high of $13.76. The company has a market cap of $894.08 million, a PE ratio of -2.35 and a beta of 0.51. The company has a quick ratio of 1.29, a current ratio of 1.29 and a debt-to-equity ratio of 0.06.

agilon health (NYSE:AGLGet Free Report) last issued its quarterly earnings data on Thursday, November 7th. The company reported ($0.29) EPS for the quarter, missing the consensus estimate of ($0.10) by ($0.19). The company had revenue of $1.45 billion during the quarter, compared to the consensus estimate of $1.47 billion. agilon health had a negative return on equity of 47.84% and a negative net margin of 6.88%. During the same quarter last year, the company posted ($0.06) earnings per share. As a group, equities research analysts forecast that agilon health, inc. will post -0.47 earnings per share for the current year.

About agilon health

(Free Report)

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.

Featured Stories

Want to see what other hedge funds are holding AGL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for agilon health, inc. (NYSE:AGLFree Report).

Institutional Ownership by Quarter for agilon health (NYSE:AGL)

Receive News & Ratings for agilon health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for agilon health and related companies with MarketBeat.com's FREE daily email newsletter.